Dr. Umaru's Blog on Health & Development

  Inside a $5 Billion Federal Pursuit: What Capture Strategy Looks Like in Practice A behind-the-scenes look at how a $14.4 billion company entered a new federal market and won. Why a $14.4 Billion Company Needed a New Plan In the fourth quarter of 2025, a privately held defense and logistics firm reported $14.4 billion in annual revenue, with four percent growth. Most of that business came from long-standing work with the Pentagon, NASA, and the national security community. That level of revenue can look like security. For the board, however, it also revealed concentration risk. When a business depends heavily on one kind of customer, a program cancellation, budget shift, or more aggressive competitor can quickly threaten revenue that once seemed stable. To reduce that exposure, the company looked to the federal government as a funding source large and steady enough to support a second business line. It chose the global health supply chain, a market it had never entered be...

How a 70 Percent Stock-Out Rate Fell to 2 Percent: Rebuilding Zambia's Laboratory Supply Chain For years, Zambia's laboratory program ran short of the basic supplies that keep patients tested and staff safe. CD4 test kits, viral load reagents, gentian violet stain, gloves, and other personal protective equipment were often missing from the shelf. Without them, laboratories could not support the country's HIV/AIDS, tuberculosis, malaria, and maternal and child health services. The situation was dire. At baseline, more than 70 percent of essential reagents were out of stock. The few reagents that were available often came in the wrong mix. A single test might require four items, such as a test kit, saline solution, decontamination solution, and a lyophilized reagent, yet a laboratory would have only two of them on hand. The other two sat unused. Equipment told the same story. Analyzers broke down and stayed down because there was no maintenance contract, no service provider, ...